相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Subunit microparticulate vaccine delivery using microneedles trigger significant SARS-spike-specific humoral and cellular responses in a preclinical murine model
Smital Patil et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)
Laser-assisted intradermal delivery of a microparticle vaccine for respiratory syncytial virus induces a robust immune response
Ipshita Menon et al.
VACCINE (2023)
An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice
Sharon Vijayanand et al.
PHARMACEUTICS (2023)
A dual-delivery platform for vaccination using antigen-loaded nanoparticles in dissolving microneedles
Keegan Braz Gomes et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
A single-shot vaccine approach for the universal influenza A vaccine candidate M2e
Ranmali Kavishna et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants
Jenny E. Hernandez-Davies et al.
SCIENTIFIC REPORTS (2022)
Novel microparticulate Zika vaccine induces a significant immune response in a preclinical murine model after intramuscular administration
Akanksha Kale et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated Neisseria gonorrhoeae Microparticle Vaccine Formulation
Priyal Bagwe et al.
VACCINES (2022)
Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery
Keegan Braz Gomes et al.
VIRUSES-BASEL (2022)
Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus
Sharon Vijayanand et al.
VACCINES (2022)
Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route
Trinh Phuong Vo et al.
PHARMACEUTICALS (2022)
Virus-like particle vaccinology, from bench to bedside
Mona O. Mohsen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus
Kimberly Braz Gomes et al.
VACCINES (2021)
Microneedles: A New Generation Vaccine Delivery System
Ipshita Menon et al.
MICROMACHINES (2021)
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
Yue Su et al.
DRUG DELIVERY (2021)
Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
Hae-Ji Kang et al.
PLOS ONE (2019)
Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)-Mediated Anti-tumor Therapy
Julia Koerner et al.
FRONTIERS IN IMMUNOLOGY (2019)
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
Matthew Zirui Tay et al.
FRONTIERS IN IMMUNOLOGY (2019)
M2e-based universal influenza vaccines: a historical overview and new approaches to development
Daria Mezhenskaya et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection
D. G. Eliasson et al.
MUCOSAL IMMUNOLOGY (2018)
Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement
Dan Dou et al.
FRONTIERS IN IMMUNOLOGY (2018)
Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus
Ki-Hye Kim et al.
VACCINES (2018)
Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies
Marc Rondy et al.
JOURNAL OF INFECTION (2017)
Dissolving microneedles for transdermal drug delivery: Advances and challenges
Kevin Ita
BIOMEDICINE & PHARMACOTHERAPY (2017)
Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody
Ki Joon Cho et al.
JOURNAL OF VIROLOGY (2016)
PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
A. L. Silva et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Repeated flu shots may blunt effectiveness
Terry Murray
CANADIAN MEDICAL ASSOCIATION JOURNAL (2015)
Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection
Min-Chul Kim et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Structure of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus in Complex with a Protective Monoclonal Antibody
Ki Joon Cho et al.
JOURNAL OF VIROLOGY (2015)
Advances in aluminum hydroxide-based adjuvant research and its mechanism
Peng He et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells
Zhenzhen Liu et al.
Frontiers in Physiology (2015)
Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines
Yu-Na Lee et al.
IMMUNE NETWORK (2015)
Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin
Liudmila A. Stepanova et al.
PLOS ONE (2015)
Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
Saranya Sridhar et al.
VACCINES (2015)
Continuing challenges in influenza
Robert G. Webster et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS: INFECTIOUS DISEASES OF CURRENT AND EMERGING CONCERN (2014)
Biodegradable Particles as Vaccine Delivery Systems: Size Matters
Vijaya B. Joshi et al.
AAPS JOURNAL (2013)
Traditional and New Influenza Vaccines
Sook-San Wong et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Multi-faceted functions of secretory IgA at mucosal surfaces
Blaise Corthesy
FRONTIERS IN IMMUNOLOGY (2013)
Mechanisms of action of adjuvants
Sunita Awate et al.
FRONTIERS IN IMMUNOLOGY (2013)
Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut
N. J. Mantis et al.
MUCOSAL IMMUNOLOGY (2011)
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
Moses O. Oyewumi et al.
EXPERT REVIEW OF VACCINES (2010)
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
Arnaud M. Didierlaurent et al.
JOURNAL OF IMMUNOLOGY (2009)
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
C. R. Casella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
Sandra L. Giannini et al.
VACCINE (2006)
Microparticle-based technologies for vaccines
Derek T. O'Hagan et al.
METHODS (2006)
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Y Waeckerle-Men et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)